843646-72-0 Usage
Description
3-(2-Acetamidyl)phenylboronic acid pinacol ester is a boronic acid pinacol ester derivative with the chemical formula C16H23BNO4. It features a phenylboronic acid group and an acetamidyl group, making it a versatile compound in organic synthesis and medicinal chemistry.
Uses
Used in Organic Synthesis:
3-(2-Acetamidyl)phenylboronic acid pinacol ester is used as a synthetic intermediate for the formation of carbon-carbon and carbon-heteroatom bonds. Its boronic acid functionality allows for the construction of complex molecular structures, facilitating the synthesis of various organic compounds.
Used in Medicinal Chemistry:
In the pharmaceutical industry, 3-(2-Acetamidyl)phenylboronic acid pinacol ester is used as a key building block in the development of biologically active compounds. Its unique structure and reactivity enable the creation of novel drug candidates with potential therapeutic applications.
Used in Drug Development:
3-(2-Acetamidyl)phenylboronic acid pinacol ester is utilized as a precursor in the synthesis of pharmaceuticals. Its versatility and reactivity contribute to the discovery and optimization of new drugs with improved efficacy and selectivity.
Overall, 3-(2-Acetamidyl)phenylboronic acid pinacol ester is a valuable chemical entity in the fields of organic synthesis and medicinal chemistry, playing a crucial role in the development of innovative pharmaceuticals and complex organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 843646-72-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,3,6,4 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 843646-72:
(8*8)+(7*4)+(6*3)+(5*6)+(4*4)+(3*6)+(2*7)+(1*2)=190
190 % 10 = 0
So 843646-72-0 is a valid CAS Registry Number.
843646-72-0Relevant articles and documents
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
-
Page/Page column 30, (2010/07/03)
New (3-oxo)pyridazin-4-ylurea derivatives having the chemcial structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of the phosphodiesterase IV (PDE4).